home / stock / atxi / atxi news

ATXI News and Press, Avenue Therapeutics Inc.

Stock Information
Company Name: Avenue Therapeutics Inc.
Stock Symbol: ATXI
Market: NASDAQ
Website: avenuetx.com
Menu
ATXI ATXI Quote ATXI Short ATXI News ATXI Articles ATXI Message Board
Get ATXI Alerts

News, Short Squeeze, Breakout and More Instantly...
ATXI - Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...
ATXI - Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the ...

ATXI - Avenue Therapeutics GAAP EPS of $15.40 beats by $24.40

2024-05-16 01:35:18 ET More on Avenue Therapeutics Avenue Therapeutics drops 9% on 1-for-75 reverse split Avenue Therapeutics granted extension for Nasdaq compliance Seeking Alpha’s Quant Rating on Avenue Therapeutics Historical earnings data for Avenu...

ATXI - Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutica...
ATXI - Expected US Company Earnings on Friday, May 10th, 2024

Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...

ATXI - Avenue Therapeutics files to sell 1.42M shares

2024-05-06 15:14:53 ET More on Avenue Therapeutics Avenue Therapeutics drops 9% on 1-for-75 reverse split Avenue Therapeutics granted extension for Nasdaq compliance Seeking Alpha’s Quant Rating on Avenue Therapeutics Historical earnings data for Avenu...

ATXI - US Companies Moving the Markets, Evening edition
Mon, Apr 29, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Tesla Inc. (TSLA) rose 15.3% to $194.05 on volume of 241,483,966 shares SiNtx Technologies Inc. (SINT) rose 34.9% to $0.0545 on volume of 171,893,463 shares Collective Audience Inc. (CAUD) rose 61.6% to $0.6301 on volume of 156,906,40...
ATXI - ImmunityBio, Aquestive Therapeutics, Clever Leaves Holdings among healthcare movers

2024-04-29 10:02:54 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...

ATXI - US Companies Moving the Markets, Morning edition
Mon, Apr 29, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States SoFi Technologies Inc. (SOFI) fell 9.7% to $7.1068 on volume of 45,729,887 shares Tesla Inc. (TSLA) rose 11.6% to $187.7701 on volume of 45,057,076 shares Collective Audience Inc. (CAUD) rose 71.6% to $0.669199 on volume of 34,955,653...

ATXI - ALT, CYCC and DB among pre-market losers

2024-04-29 08:17:37 ET More on pre-market losers & stocks. Deutsche Bank AG (DB) Q1 2024 Earnings Call Transcript Deutsche Bank May Knock Q1 Estimates Out Of The Park Buy Altimmune's Potential Market Disruption With Pemvidutide Deutsche Bank reports 10%Y/...
Next 10